Soru

Zorluk: OrtaGeneral Internal Medicine

Emergency medical services bring a somnolent 7171-year-old male to the emergency department following three days of escalating dyspnea and increased purulent sputum production. His family reports that he has been excessively sleepy since this morning.

His medical history is significant for severe chronic obstructive pulmonary disease (COPD), ischemic cardiomyopathy with a left ventricular ejection fraction of 40%40\%, and hypothyroidism. Home medications include lisinopril, metoprolol succinate, tiotropium, and levothyroxine.

On arrival, his temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}), blood pressure is 138/82 mm Hg138/82\text{ mm Hg}, pulse is 108/min108/\text{min}, and respiratory rate is 26/min26/\text{min}. Pulse oximetry reveals an oxygen saturation of 86%86\% on ambient air.

Physical examination shows an obtunded patient who arouses only to painful stimuli. The jugular veins are flat when the patient is positioned at 45∘45^\circ. Cardiac auscultation demonstrates a tachycardic, regular rhythm without murmurs, rubs, or gallops. Lung auscultation reveals a markedly prolonged expiratory phase with diffuse bilateral wheezing, but no crackles are appreciated. The lower extremities show no pitting edema.

Initial laboratory and diagnostic studies reveal the following:

Leukocyte count: 14,500/\muL14,500/\text{\mu L}

Arterial blood gas (ambient air):
pH: 7.247.24
PaCO 2_2: 72 mm Hg72\text{ mm Hg}
PaO 2_2: 52 mm Hg52\text{ mm Hg}
HCO 3−_3^-: 30 mEq/L30\text{ mEq/L}

Thyroid-stimulating hormone (TSH): 0.2 mIU/L0.2\text{ mIU/L} (Reference: 0.5−5.0 mIU/L0.5 - 5.0\text{ mIU/L})
Free T4: 0.7 ng/dL0.7\text{ ng/dL} (Reference: 0.9−1.7 ng/dL0.9 - 1.7\text{ ng/dL})

A portable chest radiograph displays hyperinflated lung fields and flattened hemidiaphragms, with no focal consolidations, pleural effusions, or pulmonary venous congestion. A sputum Gram stain demonstrates numerous polymorphonuclear leukocytes and Gram-negative coccobacilli.

Which of the following is the most appropriate initial management for this patient's current condition?

  1. Start noninvasive positive-pressure ventilation, systemic glucocorticoids, and azithromycin.Cevap
  2. B
    Administer intravenous furosemide and sublingual nitroglycerin.
  3. C
    Administer an intravenous infusion of sodium bicarbonate.
  4. D
    Initiate empiric therapy with intravenous vancomycin and cefepime.
  5. E
    Administer intravenous levothyroxine and hydrocortisone.

Cevap

The most appropriate initial management is to start noninvasive positive-pressure ventilation (NIPPV), systemic glucocorticoids, and targeted antibiotic therapy such as azithromycin.
This patient is experiencing a severe acute exacerbation of COPD, complicated by acute-on-chronic hypercapnic respiratory failure and encephalopathy. The diagnosis is supported by the history of COPD, purulent sputum, diffuse wheezing, and hyperinflated lungs on radiography without signs of left-sided heart failure. The arterial blood gas demonstrates a severe respiratory acidosis (pH 7.247.24, elevated PaCO 2_2) necessitating immediate ventilatory support. Since he is obtunded but potentially arousable, a trial of noninvasive positive-pressure ventilation (NIPPV) is the preferred initial respiratory intervention to improve gas exchange and reduce the work of breathing. Concurrent medical therapy should include systemic glucocorticoids to reduce airway inflammation and inhaled bronchodilators. Furthermore, the sputum Gram stain revealing Gram-negative coccobacilli strongly suggests Haemophilus influenzae or Moraxella catarrhalis. Narrow-spectrum targeted antimicrobial therapy (such as azithromycin) is indicated, strictly adhering to antimicrobial stewardship principles.

Adım Adım Çözüm

1
Differentiate the cause of acute respiratory failure based on clinical presentation.
The patient has hyperinflated lungs, wheezing, and purulent sputum, pointing to an acute COPD exacerbation. He lacks signs of volume overload (flat neck veins, clear CXR) that would suggest heart failure.
Patients with comorbid COPD and heart failure require careful physical exam and imaging synthesis to determine the primary acute driver of their dyspnea.
2
Interpret the arterial blood gas to guide respiratory support.
A pH of 7.24 with a PaCO2 of 72 mm Hg indicates a severe, acute-on-chronic respiratory acidosis. His somnolence is a classic sign of CO2 narcosis.
Severe hypercapnic respiratory failure in COPD is a primary indication for a trial of noninvasive positive-pressure ventilation (NIPPV).
3
Determine the appropriate antimicrobial coverage based on preliminary data.
The Gram stain shows Gram-negative coccobacilli, characteristic of Haemophilus influenzae or Moraxella catarrhalis. A macrolide like azithromycin is appropriate.
Antimicrobial stewardship dictates using targeted, narrow-spectrum agents rather than broad-spectrum antibiotics unless specific risk factors for resistant organisms are present.
4
Analyze the incidental thyroid function tests in the context of critical illness.
Both TSH and free T4 are low, diagnosing euthyroid sick syndrome (non-thyroidal illness) rather than primary hypothyroidism/myxedema coma.
Thyroid hormone supplementation is contraindicated in euthyroid sick syndrome; the abnormalities typically resolve once the underlying acute illness is treated.

Anahtar Kavram

Management of acute hypercapnic respiratory failure in a COPD exacerbation requires NIPPV, systemic corticosteroids, and targeted antibiotics, while avoiding misinterpretation of concurrent physiologic derangements like euthyroid sick syndrome.
Tahmini Süre:1m 30s
Bu soruyu puanla